Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2018-07-13 2018-07-13
Drug Identification Number 02245458 02245458
Brand name SODIUM AUROTHIOMALATE INJECTION BP SODIUM AUROTHIOMALATE INJECTION BP
Common or Proper name AUROTHIOMALATE AUROTHIOMALATE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients GOLD SODIUM THIOMALATE GOLD SODIUM THIOMALATE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 VIALS 10 VIALS
ATC code M01CB M01CB
ATC description SPECIFIC ANTIRHEUMATIC AGENTS SPECIFIC ANTIRHEUMATIC AGENTS
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date 2016-08-31 2016-08-31
Actual discontinuation date 2016-09-10 2016-09-10
Remaining supply date 2016-09-10 2016-09-10
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments